These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9531598)

  • 1. Tumor B cells from non-Hodgkin's lymphoma are resistant to CD95 (Fas/Apo-1)-mediated apoptosis.
    Plumas J; Jacob MC; Chaperot L; Molens JP; Sotto JJ; Bensa JC
    Blood; 1998 Apr; 91(8):2875-85. PubMed ID: 9531598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the CD40 and CD95 (APO-1/Fas) antigens in the apoptosis of human B-cell malignancies.
    Wang D; Freeman GJ; Levine H; Ritz J; Robertson MJ
    Br J Haematol; 1997 May; 97(2):409-17. PubMed ID: 9163608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway.
    Schattner EJ; Elkon KB; Yoo DH; Tumang J; Krammer PH; Crow MK; Friedman SM
    J Exp Med; 1995 Nov; 182(5):1557-65. PubMed ID: 7595225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of the CD95 receptor and defect CD40-mediated signal transduction in B-chronic lymphocytic leukemia cells.
    Laytragoon-Lewin N; Duhony E; Bai XF; Mellstedt H
    Eur J Haematol; 1998 Oct; 61(4):266-71. PubMed ID: 9820634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Fas-mediated apoptosis by antigen: implications for lymphomagenesis.
    Schattner EJ; Friedman SM; Casali P
    Autoimmunity; 2002 Jul; 35(4):283-9. PubMed ID: 12482198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of bcl-xL expression and Fas susceptibility in mouse B cells by CD40 ligation, surface IgM crosslinking and IL-4.
    Koizumi T; Wang J; Suzuki Y; Masuda K; Watanabe T
    Mol Immunol; 1996 Nov; 33(16):1247-53. PubMed ID: 9129161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity to Fas-mediated apoptosis is null or weak in B-cell non-Hodgkin's lymphomas and is moderately increased by CD40 ligation.
    Xerri L; Bouabdallah R; Devilard E; Hassoun J; Stoppa AM; Birg F
    Br J Cancer; 1998 Jul; 78(2):225-32. PubMed ID: 9683298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to HLA class I alpha1 domain trigger apoptosis of CD40-activated human B lymphocytes.
    Genestier L; Meffre G; Garrone P; Pin JJ; Liu YJ; Banchereau J; Revillard JP
    Blood; 1997 Jul; 90(2):726-35. PubMed ID: 9226173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of CD95 antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease.
    Nguyen PL; Harris NL; Ritz J; Robertson MJ
    Am J Pathol; 1996 Mar; 148(3):847-53. PubMed ID: 8774139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased inhibition of proliferation of human B cell lymphomas following ligation of CD40, and either CD19, CD20, CD95 or surface immunoglobulin.
    Benoit NE; Wade WF
    Immunopharmacology; 1996 Nov; 35(2):129-39. PubMed ID: 8956976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid CD40-mediated rescue from CD95-induced apoptosis requires TNFR-associated factor-6 and PI3K.
    Benson RJ; Hostager BS; Bishop GA
    Eur J Immunol; 2006 Sep; 36(9):2535-43. PubMed ID: 16897814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4+ T-cell induction of Fas-mediated apoptosis in Burkitt's lymphoma B cells.
    Schattner EJ; Mascarenhas J; Bishop J; Yoo DH; Chadburn A; Crow MK; Friedman SM
    Blood; 1996 Aug; 88(4):1375-82. PubMed ID: 8695856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High CD40 membrane expression in AIDS-related lymphoma B cell lines is associated with the CD45RA+, CD45RO+, CD95+ phenotype and high levels of its soluble form in culture supernatants.
    De Paoli P; Cozzi M; Tedeschi R; Gloghini A; Cilia AM; van Kooten C; Gaidano G; Carbone A
    Cytometry; 1997 Feb; 30(1):33-8. PubMed ID: 9056740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysregulation of CD95/CD95 ligand-apoptotic pathway in CD3(+) large granular lymphocyte leukemia.
    Lamy T; Liu JH; Landowski TH; Dalton WS; Loughran TP
    Blood; 1998 Dec; 92(12):4771-7. PubMed ID: 9845544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fas/APO-1 (CD95)-mediated cytotoxicity is responsible for the apoptotic cell death of leukaemic cells induced by interleukin-2-activated T cells.
    Komada Y; Zhou YW; Zhang XL; Chen TX; Tanaka S; Azuma E; Sakurai M
    Br J Haematol; 1997 Jan; 96(1):147-57. PubMed ID: 9012700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-7 sensitizes human pre-B cells but not pro-B cells to Fas/APO-1 (CD95)-mediated apoptosis.
    Levy Y; Benlagha K; Buzyn A; Colombel M; Brouet JC; Lassoued K
    Clin Exp Immunol; 1997 Nov; 110(2):329-35. PubMed ID: 9367421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of non-Hodgkin's lymphoma via HVEM: an alternate and safe way to increase Fas-induced apoptosis and improve tumor immunogenicity.
    Costello RT; Mallet F; Barbarat B; Schiano De Colella JM; Sainty D; Sweet RW; Truneh A; Olive D
    Leukemia; 2003 Dec; 17(12):2500-7. PubMed ID: 14562115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance to CD95-mediated apoptosis through constitutive c-FLIP expression in a non-Hodgkin's lymphoma B cell line.
    Irisarri M; Plumas J; Bonnefoix T; Jacob MC; Roucard C; Pasquier MA; Sotto JJ; Lajmanovich A
    Leukemia; 2000 Dec; 14(12):2149-58. PubMed ID: 11187905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rituximab-induced inhibition of YY1 and Bcl-xL expression in Ramos non-Hodgkin's lymphoma cell line via inhibition of NF-kappa B activity: role of YY1 and Bcl-xL in Fas resistance and chemoresistance, respectively.
    Vega MI; Jazirehi AR; Huerta-Yepez S; Bonavida B
    J Immunol; 2005 Aug; 175(4):2174-83. PubMed ID: 16081784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impairment of death-inducing signalling complex formation in CD95-resistant human primary lymphoma B cells.
    Lajmanovich A; Irisarri M; Molens JP; Pasquier MA; Sotto JJ; Bensa JC; Leroux D; Plumas J
    Br J Haematol; 2004 Mar; 124(6):746-53. PubMed ID: 15009062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.